Index/NAPNootropic & Cognitive

NAP

Davunetide · AL-108 · NAPVSIPQ

8-amino acid neuroprotective peptide — tau and microtubule stabilization.

FDA

Research Only

WADA

Not Listed

HALF-LIFE

~Hours

ROUTE

Intranasal

SCHEDULE

Daily

In Plain English

8-amino acid neuroprotective peptide — tau and microtubule stabilization.

Status & Legality

What do these mean?

NATTY?

?
No Test Exists

No established test exists for this compound.

FDA

?
Research Only

For research purposes only. Not FDA approved.

WADA

?
Not Listed

Not currently on WADA prohibited list.

COMPOUNDING

?
Not from pharmacies

Not available from licensed compounding pharmacies.

PRESCRIBED

?
Not prescribed

Not prescribed in conventional medicine.

ROUTE

?
Intranasal

Administration via intranasal.

Who It's For

Neuroprotection

Tau pathology

Alzheimer's prevention

Cognitive preservation

How It Works

NAP (NAPVSIPQ) is an 8-amino acid peptide derived from activity-dependent neuroprotective protein (ADNP). It stabilizes microtubules, reduces tau hyperphosphorylation, and provides potent neuroprotection at femtomolar concentrations. Phase II trials in Alzheimer's and schizophrenia showed cognitive improvements via intranasal delivery. Among the most potent neuroprotective sequences known.

Side Effects

01

Nasal irritation

02

Headache (uncommon)

03

Generally excellent safety profile at research doses

Common Mistakes

Assuming more is better — NAP is effective at femtomolar concentrations; Phase II trials used 5–30 mcg; exceeding this doesn't improve outcomes and may reduce selectivity

Not using intranasal delivery — oral NAP does not meaningfully reach the CNS; intranasal is the only route with clinical evidence

Expecting immediate cognitive changes — neuroprotection is cumulative over months; short-term cognition enhancement is not NAP's primary mechanism

Drug & Supplement Interactions

Cerebrolysin — complementary neuroprotection; tau stabilization (NAP) + neurotrophic support (Cerebrolysin) for comprehensive CNS coverage

Semax — synergistic; microtubule stabilization (NAP) + BDNF/NGF upregulation (Semax) for the most evidence-based nootropic pairing

No known significant adverse drug interactions at research doses

The PepVault Take

NAP is extraordinary in its potency — effective at doses 1,000× lower than most research peptides. The tau-stabilizing and microtubule-protective effects make it the most specific Alzheimer's-preventive peptide available today. 30 mcg intranasal daily + Semax 300 mcg is the best neuroprotection stack in this entire index for long-term cognitive preservation.

Frequently Asked Questions

Similar & Complementary

Free, no account needed

New to NAP? Grab the starter checklist.

Drop your email and we'll send the one-page starter checklist beginners actually need first. No account needed.

No spam, and we never sell your email. Just the checklist. Email support@pepvault.us to opt out any time.

Common questions about NAP

Stats

ONSET50
DOCUMENTATION18
SIDE INTENSITY38
CYCLE EASE60
POPULARITY25
Add to My Stack

Sources & Studies

1/2
Research Use OnlyNot Medical AdviceNot FDA Evaluated18+ OnlyWADA Status Tracked

PepVault provides educational and research reference information only. Nothing on this site constitutes medical advice, diagnosis, or treatment. Content has not been evaluated by the U.S. Food and Drug Administration. No compound listed on this site is intended to diagnose, treat, cure, or prevent any disease or medical condition. The legality of peptide compounds varies by jurisdiction — you are solely responsible for compliance with the laws of your country or region. Certain compounds listed are prohibited under the World Anti-Doping Agency (WADA) Prohibited List; athletes subject to anti-doping regulations should independently verify status before use. This site is intended for adults 18 years of age or older. Always consult a licensed healthcare provider before using any compound.

© 2026 PepVault. All rights reserved.